We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+2.6%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.34B
AUM Growth
+$209M
Cap. Flow
+$157M
Cap. Flow %
4.72%
Top 10 Hldgs %
12.01%
Holding
1,564
New
189
Increased
576
Reduced
529
Closed
163

Sector Composition

Rank Sector Weight
1 Energy 11.94%
2 Healthcare 10.62%
3 Industrials 9.8%
4 Technology 9.43%
5 Financials 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANDV
1126
DELISTED
Andeavor
ANDV
$250K 0.01%
4,954
+2
+0% +$104
RGC
1127
DELISTED
Regal Entertainment Group
RGC
$249K 0.01%
13,325
+635
+5% +$12.2K
VHC icon
1128
VirnetX Holding Corp
VHC
$54.6M
$248K 0.01%
+875
New +$305K
NAV
1129
DELISTED
Navistar International
NAV
$248K 0.01%
7,323
+1,195
+20% +$42.3K
FGP
1130
DELISTED
Ferrellgas Partners, L.P.
FGP
$248K 0.01%
10,700
+1,500
+16% +$36K
AIR icon
1131
AAR Corp
AIR
$5.45B
$247K 0.01%
+9,533
New +$266K
FTF
1132
Franklin Limited Duration Income Trust
FTF
$231M
$247K 0.01%
18,960
-785
-4% -$10.3K
IRM icon
1133
Iron Mountain
IRM
$36.5B
$247K 0.01%
9,693
+541
+6% +$13.8K
PSP icon
1134
Invesco Global Listed Private Equity ETF
PSP
$233M
$247K 0.01%
4,072
-21,374
-84% -$1.29M
PPS
1135
DELISTED
Post Properties
PPS
$245K 0.01%
+4,993
New +$238K
XSD icon
1136
State Street SPDR S&P Semiconductor ETF
XSD
$2.7B
$244K 0.01%
+7,078
New +$227K
IO
1137
DELISTED
ION Geophysical Corporation
IO
$244K 0.01%
3,867
+3,067
+383% +$168K
CCEP icon
1138
Coca-Cola Europacific Partners
CCEP
$48.4B
$243K 0.01%
5,100
-561
-10% -$25.6K
DGX icon
1139
Quest Diagnostics
DGX
$25.8B
$243K 0.01%
+4,201
New +$225K
NDLS icon
1140
Noodles & Co
NDLS
$106M
$242K 0.01%
767
-72
-9% -$21.6K
PBE icon
1141
Invesco Biotechnology & Genome ETF
PBE
$278M
$242K 0.01%
5,821
-226
-4% -$9.67K
STON
1142
DELISTED
StoneMor Inc.
STON
$242K 0.01%
9,620
-1,268
-12% -$32.2K
DWAS icon
1143
Invesco Dorsey Wright SmallCap Momentum ETF
DWAS
$434M
$241K 0.01%
6,139
-11,582
-65% -$457K
KWEB icon
1144
KraneShares CSI China Internet ETF
KWEB
$5.55B
$241K 0.01%
+6,700
New +$240K
NHS
1145
Neuberger High Yield Strategies Fund Inc
NHS
$252M
$241K 0.01%
17,661
-1,500
-8% -$20.3K
NS
1146
DELISTED
NuStar Energy L.P.
NS
$241K 0.01%
4,400
-1,612
-27% -$82.5K
APAGF
1147
DELISTED
APCO OIL AND GAS INTERNATIONAL INC
APAGF
$241K 0.01%
16,695
+5,000
+43% +$72.2K
MEMP
1148
DELISTED
Memorial Production Partners LP Common Units
MEMP
$241K 0.01%
+10,664
New +$236K
MLI icon
1149
Mueller Industries
MLI
$14.8B
$240K 0.01%
32,000
THRM icon
1150
Gentherm
THRM
$1.26B
$240K 0.01%
+6,918
New +$194K

Similar funds

Oppenheimer & Co's Q1 2014 Portfolio in Review

As of Q1 2014, Oppenheimer & Co held 1,564 positions worth $3.34B, up 6.7% from $3.13B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Oppenheimer & Co deployed $157M of net new capital in Q1 2014, opening 189 new positions and adding to 576 existing holdings. Its largest new stake was Vanguard Morningstar Total Stock Market ETF: 169,083 shares worth $16.5M.

By sector, the portfolio is most concentrated in Energy at 12% of assets, down from 12% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Vanguard Dividend Appreciation ETF, an estimated $7.79M trimmed.

  • Oppenheimer & Co's largest Q1 2014 buy was Vanguard Morningstar Total Stock Market ETF: 169,083 shares worth $16.5M.
  • Oppenheimer & Co added most to Monsanto Co in Q1 2014, an estimated $30M increase.
  • Oppenheimer & Co's biggest Q1 2014 reduction was Vanguard Dividend Appreciation ETF, cutting an estimated $7.79M.
  • Oppenheimer & Co fully exited TetraLogic Pharmaceuticals Corporation in Q1 2014, selling an estimated $10.2M.
  • Oppenheimer & Co's ten largest holdings make up 12% of its $3.34B portfolio in Q1 2014.
  • Oppenheimer & Co opened 189 new positions and closed 163 in Q1 2014.
  • Oppenheimer & Co's portfolio value rose 6.7% quarter-over-quarter to $3.34B.

Based on Oppenheimer & Co's 13F filing for Q1 2014, filed 9 May 2014.